|
EPB41L4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.160200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.765000E-01 |
| Normal-vs-Stage2 |
2.269200E-01 |
| Normal-vs-Stage3 |
1.132440E-01 |
| Normal-vs-Stage4 |
1.418180E-02 |
| Stage1-vs-Stage2 |
4.859400E-01 |
| Stage1-vs-Stage3 |
2.474400E-01 |
| Stage1-vs-Stage4 |
2.234200E-02 |
| Stage2-vs-Stage3 |
7.911600E-01 |
| Stage2-vs-Stage4 |
2.381000E-01 |
| Stage3-vs-Stage4 |
3.008200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.368020E-01 |
| Normal-vs-AfricanAmerican |
7.960200E-01 |
| Normal-vs-Asian |
4.680200E-01 |
| Caucasian-vs-AfricanAmerican |
1.888160E-01 |
| Caucasian-vs-Asian |
4.224400E-01 |
| AfricanAmerican-vs-Asian |
4.801200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.611400E-01 |
| Normal-vs-Female |
5.938100E-02 |
| Male-vs-Female |
3.932400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.748800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.462960E-01 |
| Normal-vs-Age(61-80Yrs) |
1.618980E-01 |
| Normal-vs-Age(81-100Yrs) |
1.993820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.829000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.087800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.291500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.503400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.933700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.349810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.255300E-03 |
| Classical-VS-Follicular |
8.595400E-01 |
| Classical-VS-Other |
4.039200E-01 |
| Classical-VS-Normal |
4.022200E-01 |
| Tall-VS-Follicular |
3.429800E-02 |
| Tall-VS-Other |
1.261420E-01 |
| Tall-VS-Normal |
5.597900E-03 |
| Follicular-VS-Other |
3.641800E-01 |
| Follicular-VS-Normal |
3.688000E-01 |
| Other-VS-Normal |
6.025800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.399820E-01 |
| Normal-vs-N1 |
6.258200E-02 |
| N0-vs-N1 |
3.782800E-01 |
|
|
